About

Zaid Aqrawe, PhD, qualified as a pharmacist from the University of Auckland in New Zealand, Dr Aqrawe completed his PhD on the delivery of bioactive molecules from implantable drug delivery systems. He then specialised in adapting these drug delivery systems for neurological conditions, such as spinal cord injury. His area of expertise and interest lies in the delivery of biomolecules through complex medical devices.

Contributions

EXPERT VIEW

SOFT MIST INHALERS VERSUS NEBULISERS: DELIVERY EQUIVALENCE & FUTURE THERAPIES

Zaid Aqrawe, Philippe Rogueda, Darragh Murnane and Bryan Eng, discuss the opportunity presented by soft mist inhalers as an alternative delivery device to nebulisers for inhaled therapies, contrasting the two device categories across multiple factors.